A potential role of preexisting inflammation in the development of acute myelopathy following CAR T-cell therapy for diffuse large B-cell lymphoma

2022 ◽  
Vol 70 (2) ◽  
pp. 103331
Author(s):  
David Beauvais ◽  
Adeline Cozzani ◽  
Anne-Sophie Blaise ◽  
Anne-Sophie Moreau ◽  
Pauline Varlet ◽  
...  
Keyword(s):  
Cell Therapy ◽  
Potential Role ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
T Cell Therapy ◽  
Large B Cell Lymphoma ◽  
Car T Cell Therapy ◽  
Car T ◽  
Large B Cell

Refining patient selection for CAR T-cell therapy in aggressive large B-cell lymphoma

2019 ◽  
Vol 61 (4) ◽  
pp. 799-807 ◽  
Author(s):  
Kirk E. Cahill ◽  
Michael J. Leukam ◽  
Peter A. Riedell
Keyword(s):  
Cell Therapy ◽  
Patient Selection ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
T Cell Therapy ◽  
Large B Cell Lymphoma ◽  
Car T Cell Therapy ◽  
Car T ◽  
Selection For ◽  
Large B Cell

scholarly journals Rapid relapse of large B‐cell lymphoma after CD19 directed CAR‐T‐cell therapy due to CD‐19 antigen loss

2019 ◽  
Vol 94 (10) ◽  
Author(s):  
Ali Bukhari ◽  
Firas El Chaer ◽  
Rima Koka ◽  
Zeba Singh ◽  
Elizabeth Hutnick ◽  
...  
Keyword(s):  
Cell Therapy ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
T Cell Therapy ◽  
Large B Cell Lymphoma ◽  
Car T Cell Therapy ◽  
Car T ◽  
Antigen Loss ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document